Skip to main content

BRIEF-Cynata Therapeutics says FDA Grants orphan drug designation to cymerus msc product, cyp-001

* FDA GRANTS ORPHAN DRUG DESIGNATION TO CYNATA’S LEAD CYMERUS™ MSC PRODUCT, CYP-001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.